RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
about
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNAThe apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decayAntisense-mediated exon skipping: a versatile tool with therapeutic and research applicationsAID/APOBEC deaminases and cancerTwo proteins essential for apolipoprotein B mRNA editing are expressed from a single gene through alternative splicingRetroviral restriction by APOBEC proteinsAntisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB.Opossum APOBEC1 is a DNA mutator with retrovirus and retroelement restriction activity.APOBEC3B, a molecular driver of mutagenesis in human cancers.tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli.Linking class-switch recombination with somatic hypermutation.Genome- and proteome-based technologies: status and applications in the postgenomic era.Multiple tandem splicing silencer elements suppress aberrant splicing within the long exon 26 of the human Apolipoprotein B gene.Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.APOBEC deaminases-mutases with defensive roles for immunity.Large-scale detection of in vivo transcription errors.Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons.Predicting A-to-I RNA editing by feature selection and random forest.Widespread RNA and DNA sequence differences in the human transcriptome.Creation of chimeric human/rabbit APOBEC1 with HIV-1 restriction and DNA mutation activities.Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressorsEIYMNVPV Motif is Essential for A1CF Nucleus Localization and A1CF (-8aa) Promotes Proliferation of MDA-MB-231 Cells via Up-Regulation of IL-6.The AID/APOBEC family of nucleic acid mutators.Splicing therapeutics in SMN2 and APOB.The current structural and functional understanding of APOBEC deaminases.Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.The antiretroviral potency of APOBEC1 deaminase from small animal species.Genotyping and Bio-Sensing Chemosensory Proteins in Insects.Hippocampal Characteristics and Invariant Sequence Elements Distribution of GLRA2 and GLRA3 C-to-U EditingA strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing.APOBEC3 signature mutations in chronic lymphocytic leukemiaThe activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process.mRNA Editing: C to U ConversionDifferential in-gel electrophoresis (DIGE) analysis of CHO cells under hyperosmotic pressure: osmoprotective effect of glycine betaine addition.
P2860
Q24305266-19E5CE3C-A2A9-4B06-BE88-C97E0EBB5CCCQ24310868-AAF983FD-E81D-4191-8508-018B832EDF36Q24682555-985A5CD6-3CCC-4AA0-BB91-EA25BE12981CQ28085553-BB3140B7-AB8C-4B3A-8134-FCD400F5D669Q28216838-0BD8457F-039B-4EA5-8AD5-9E2D50FDC36FQ28290721-A50FE3AB-054B-4006-B772-94A83BDFC7DDQ33269609-EB96DF38-A5B4-471C-94EB-9F0DEA2FB72BQ33587739-E2D30555-62BB-43B1-BE1F-D370294604A0Q33743603-8E8CB494-B887-4E05-AF99-68C416E76DFBQ34089639-65E43174-BCEC-4ED6-8512-CEC2097796F5Q34297090-E1FDEC10-7E84-4CF7-8E19-AC0D14F24DF8Q34569282-A86F4982-ABC9-4FC7-BDD5-1C1F9971D058Q34580416-563F0874-F0A4-4661-AD1E-52AD3EBE70F0Q34651434-9E49B2E4-B240-4018-9E91-32172862CBF1Q35012747-B68FFD24-A51F-46FB-A1EB-E47B791753F2Q35027571-C9CA4AF8-C924-455C-934F-3544C08F4229Q35120769-CCD64C64-4794-4BB9-9DB0-A0F524F78911Q35359009-0E2006C6-BACB-4C30-B04E-3C34D59F143EQ35479706-DF25CD05-1F1E-400B-BDB5-A5F2C435CEC1Q36438515-87ACBC37-E404-457A-9C37-56184E7DF5A6Q36690990-1CF7BF74-5946-4581-8EB5-F5AC328C82E7Q37050476-9DE36AA2-457F-46BB-B4E0-FACD7022BCF1Q37206307-F6945F9F-C288-4B73-8912-8FAC1D179B68Q37426472-5660D087-6B04-4719-BF7D-392A4A75E57DQ37528123-F9B570C2-7404-4D5D-85C4-E8F5534C8B78Q39436252-F091BC98-55B6-4B02-B25D-DCE90E5AD535Q39923744-C2C696CD-D78D-4BDF-A95E-C4F40DD982EAQ41583322-50843DBC-698B-4E50-AFD2-0E2C98929121Q42211038-D055234D-4C11-439B-B46D-5D9438374944Q42288544-396910E0-0B9A-49EF-AB20-5B17789817F7Q42829578-77CDC5C0-54D1-422D-9403-5C1F0479A65AQ42944711-D5E67768-62EE-4339-869F-249A3AB4936AQ45317555-4C5B1FF5-E0C8-4EB6-99A3-20BFC082F3FEQ51761825-67B961C3-3BDC-4ED5-8E9A-49C939D0185E
P2860
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@ast
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@en
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@nl
type
label
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@ast
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@en
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@nl
prefLabel
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@ast
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@en
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@nl
P2093
P3181
P1476
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA
@en
P2093
P3181
P356
10.1016/S0167-4781(00)00219-0
P407
P577
2000-11-15T00:00:00Z